EyePoint Pharmaceuticals SG&A Expense (Quarterly) Analysis

EyePoint Pharmaceuticals Inc (EYPT)

11.83 -0.69 (-5.51%) USD | NASDAQ | May 17, 16:00

11.83 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2006. Upgrade now.

Date	Value
March 31, 2024	14.11M
December 31, 2023	11.43M
September 30, 2023	11.04M
June 30, 2023	14.34M
March 31, 2023	14.98M
December 31, 2022	14.41M
September 30, 2022	15.23M
June 30, 2022	15.44M
March 31, 2022	15.24M
December 31, 2021	17.03M
September 30, 2021	13.43M
June 30, 2021	11.84M
March 31, 2021	10.77M
December 31, 2020	11.59M
September 30, 2020	11.06M
June 30, 2020	10.88M
March 31, 2020	12.48M
December 31, 2019	11.55M
September 30, 2019	12.14M
June 30, 2019	12.10M
March 31, 2019	11.92M
September 30, 2018	7.807M
June 30, 2018	5.732M
March 31, 2018	2.281M
December 31, 2017	2.472M

Date	Value
September 30, 2017	2.572M
June 30, 2017	2.624M
March 31, 2017	2.426M
December 31, 2016	2.90M
September 30, 2016	3.285M
June 30, 2016	2.656M
March 31, 2016	2.346M
December 31, 2015	2.043M
September 30, 2015	1.968M
June 30, 2015	2.411M
March 31, 2015	2.041M
December 31, 2014	1.87M
September 30, 2014	1.734M
June 30, 2014	2.00M
March 31, 2014	1.946M
December 31, 2013	1.711M
September 30, 2013	1.811M
June 30, 2013	2.153M
March 31, 2013	1.738M
December 31, 2012	1.658M
September 30, 2012	1.62M
June 30, 2012	1.599M
March 31, 2012	1.757M
December 31, 2011	1.451M
September 30, 2011	2.061M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

10.77M

Minimum

Mar 2021

17.03M

Maximum

Dec 2021

13.06M

Average

12.31M

Median

SG&A Expense (Quarterly) Benchmarks